Skip to content

Rite Aid

Former American pharmacy and health-retail chain that grew through extensive acquisitions before entering bankruptcy and liquidating its remaining retail operations.

Last updated August 27, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Rite Aid was an American pharmacy and health-retail chain founded by Alex Grass in Scranton, Pennsylvania, in 1962 as Thrift D Discount Center. It adopted the Rite Aid name in 1968 and became one of the largest drugstore operators in the United States. Its stores combined prescription dispensing with over-the-counter medicines, personal-care products, beauty merchandise, convenience goods, photo services, vaccinations, health consultations, and other community pharmacy services. The company’s growth was driven substantially by regional acquisitions. During the 1970s and 1980s it bought chains including Read’s, Gray Drug, Begley Drug Stores, and Lane Drug. In the 1990s it expanded through purchases such as Thrifty PayLess, Harco, K&B, and other regional operators. The 1996 acquisition of Thrifty PayLess gave Rite Aid a major West Coast presence, while the 2007 purchase of Jean Coutu Group’s United States operations added the Brooks Pharmacy and Eckerd store networks. That transaction made Rite Aid the dominant drugstore retailer in much of the Eastern United States and, at its peak in 2008, brought the chain to more than 5,000 stores and over 100,000 employees. Rapid expansion also produced substantial operational and financial strain. A failed attempt to acquire Revco in the 1990s attracted antitrust scrutiny, while the company later closed hundreds of underperforming stores and sold or exited selected markets. Accounting problems, management turnover, heavy debt, and declining investor confidence pushed Rite Aid close to bankruptcy at the end of the 1990s. A management change and new financing helped it continue operating, but the company remained vulnerable to shifts in pharmacy reimbursement, competition from CVS, Walgreens, Walmart, supermarket pharmacies, mail-order providers, and emerging online channels. Rite Aid expanded into pharmacy-benefit management through PCS Health Systems and later acquired EnvisionRx in 2015. Its proposed 2015 acquisition by Walgreens Boots Alliance was abandoned after regulatory objections. Walgreens ultimately bought 1,932 Rite Aid stores and related assets in 2018, sharply reducing the scale of the remaining company. A proposed merger with Albertsons was also rejected by Rite Aid shareholders in 2018. In 2020, Rite Aid acquired Bartell Drugs, a Seattle-area chain, and in 2022 moved its headquarters from the Harrisburg-area community of East Pennsboro Township to Philadelphia. The company subsequently faced mounting debt, declining store economics, and extensive litigation concerning its alleged role in the prescription-opioid crisis. Rite Aid filed for Chapter 11 bankruptcy protection in October 2023, secured debtor-in-possession financing, and closed hundreds of stores. It emerged from bankruptcy in September 2024 after restructuring its obligations, but filed for bankruptcy again in May 2025 and proceeded toward liquidation of its remaining retail assets. The Rite Aid trademark was later transferred to an unrelated Rite Aid LLC based in Sheridan, Wyoming, which relaunched the name for a web-based blood-screening business. This later trademark use is distinct from the former national pharmacy chain.

History

Rite Aid began on September 12, 1962, when Alex Grass opened a discount drugstore in Scranton, Pennsylvania, under the name Thrift D Discount Center. The chain expanded into additional states during the 1960s and adopted the Rite Aid name before becoming a public company in 1968. It moved to the New York Stock Exchange in 1970 under the ticker RAD. By its tenth anniversary the company had 267 stores in ten states, and it continued to grow through a combination of new stores and acquisitions. During the 1970s and 1980s, Rite Aid acquired regional operators including Read’s Drug Store, Gray Drug, Begley Drug Stores, and Lane Drug. These transactions broadened its presence in the Mid-Atlantic, Midwest, and parts of the South. The company reached approximately $1 billion in sales in 1983 and surpassed 2,000 locations after a major East Coast acquisition. Expansion continued into the 1990s through purchases such as Wellby Super Drug, LaVerdiere’s, Hook’s Drug Stores, Perry Drug Stores, Thrifty PayLess, Harco, and K&B. The Thrifty PayLess acquisition in 1996 added about 1,000 stores and created a substantial West Coast operation, although Rite Aid soon sold the acquired Bi-Mart membership-store business. Rite Aid’s acquisition-led growth created increasing complexity and financial pressure. A proposed 1995 purchase of Revco was abandoned after the Federal Trade Commission raised antitrust concerns. In 1999 the company closed roughly 600 underperforming stores. Martin Grass left the chair and chief executive positions in October of that year amid mounting losses and debt-related concerns. Bob Miller subsequently became chairman and chief executive, while Mary Sammons and other experienced retail executives joined the senior leadership team. New financing and restructuring measures helped the chain avoid an immediate collapse. Rite Aid sold its pharmacy-benefit manager PCS Health Systems in 2000 and exited selected markets, including the Columbus, Ohio, store base sold to CVS in 2001. The company resumed expansion in the mid-2000s. It sold 1,260 Eckerd Pharmacy stores to CVS in 2004, then announced the acquisition of Jean Coutu Group’s United States operations in 2006. The transaction, completed in 2007 after regulatory review and store divestitures, added approximately 1,850 Brooks and Eckerd stores. Rite Aid retired the Eckerd banner and converted the acquired locations to Rite Aid stores. The combination made Rite Aid the third-largest drugstore chain in the country and produced a peak network of more than 5,000 stores in 2008. The company later closed redundant and weak locations, including stores in Las Vegas and San Francisco, and sold other locations to Walgreens. In the 2010s, Rite Aid pursued pharmacy-related growth and ownership changes. John Standley became chief executive in 2010, and Jean Coutu Group sold its remaining Rite Aid shares by 2013. Rite Aid bought EnvisionRx in 2015, expanding its pharmacy-benefit management activities. That same year Walgreens Boots Alliance proposed buying Rite Aid. Antitrust concerns led to repeated revisions, including a plan to divest hundreds of stores to Fred’s. Walgreens eventually abandoned the full acquisition in 2017 and instead bought 1,932 Rite Aid stores in a smaller transaction completed in 2018. The sale left Rite Aid with roughly 2,600 stores. A proposed merger with Albertsons was rejected by Rite Aid shareholders later in 2018. Rite Aid introduced a redesigned blue-and-green logo in 2020 and bought Bartell Drugs, a 67-store Seattle-area chain. It moved its headquarters to Philadelphia in 2022. By then, the company operated on a much smaller geographic and financial base than at its peak and faced intense competition, pharmacy reimbursement pressure, labor and operating challenges, and legal claims connected with prescription opioids. Rite Aid announced preparations for bankruptcy in August 2023 and filed for Chapter 11 protection in October. The case involved store closures, financing arrangements, and efforts to resolve or manage opioid-related litigation. The company emerged from bankruptcy in September 2024, but financial difficulties persisted. In May 2025 it filed for bankruptcy again and proceeded to liquidate its remaining retail assets. The Rite Aid trademark was subsequently transferred to an unrelated Rite Aid LLC, which used the name for a web-based blood-screening business. That later business is not the same corporate retail chain founded by Alex Grass.

  • 2025

    Second bankruptcy and retail liquidation

    [1]

    The company filed for bankruptcy again and began liquidating its remaining retail assets.

  • 2024

    Emergence from bankruptcy

    [1]

    Rite Aid completed its first court-supervised restructuring and emerged from Chapter 11.

  • 2023

    First Chapter 11 bankruptcy filing

    [1]

    Rite Aid filed for bankruptcy protection amid debt pressure, store closures, and opioid-related litigation.

  • 2020

    Bartell Drugs acquisition

    [1]

    Rite Aid bought the 67-location Bartell Drugs chain in the Seattle area.

  • 2018

    Walgreens store sale completed

    [1]

    Walgreens acquired 1,932 Rite Aid stores and associated assets after the proposed full merger was abandoned.

  • 2015

    EnvisionRx acquisition

    [1]

    Rite Aid purchased EnvisionRx, expanding into pharmacy-benefit management.

  • 2008

    Store network reaches its peak

    [1]

    Rite Aid operated more than 5,000 stores and employed over 100,000 people at the height of its expansion.

  • 2007

    Jean Coutu United States acquisition closes

    [1]

    Rite Aid acquired the United States operations of Jean Coutu Group, including Brooks and Eckerd stores, subject to divestitures.

  • 2000

    Rite Aid secures major refinancing

    [1]

    The company arranged new credit and converted part of its bank debt into equity as part of its recovery program.

  • 1999

    Large-scale store closures and management transition

    [1]

    Rite Aid closed approximately 600 underperforming stores and changed chief executive leadership amid financial distress.

Products and positioning

Mass-market community pharmacy and health retail, emphasizing neighborhood convenience, prescription access, health services, and a broad assortment of medicines and everyday consumer products.

  • Pharmacy services · 1962

    Prescription pharmacy

    Prescription dispensing was the core of Rite Aid’s retail model. Stores provided new prescriptions, refills, medication counseling, prescription records, and related pharmacist support. The pharmacy business connected the company to recurring healthcare demand while also exposing it to reimbursement pressure from insurers, pharmacy-benefit managers, government programs, and mail-order competitors.

  • Healthcare services

    Health and immunization services

    Rite Aid pharmacies offered health consultations and, in later years, immunization and vaccination services. These services were intended to position stores as accessible neighborhood healthcare locations rather than only prescription counters.

  • Healthcare retail · 1962

    Over-the-counter medicines and supplements

    Stores sold nonprescription medicines, vitamins, nutritional supplements, first-aid products, and other self-care goods. These categories complemented prescription services and provided higher-frequency consumer purchases.

  • Personal care retail · 1962

    Beauty and personal care

    Rite Aid carried cosmetics, skincare, haircare, toiletries, and related personal-care merchandise. Beauty products helped the chain compete with drugstores, mass merchants, supermarkets, and specialty retailers.

  • Pharmacy-benefit management · 2015

    EnvisionRx

    EnvisionRx was acquired in 2015 and expanded Rite Aid beyond store-based retail into pharmacy-benefit management. The business included related pharmacy-benefit entities and services for plan sponsors and healthcare customers.

Controversies

  • 2023

    Opioid-dispensing litigation and bankruptcy

    Rite Aid faced thousands of lawsuits and government claims alleging that its pharmacies contributed to the prescription-opioid crisis through inadequate controls or problematic dispensing practices. The litigation was a major factor in the company’s financial distress and its 2023 Chapter 11 filing.

  • 2020

    West Virginia sues Rite Aid and Walgreens over opioid distribution

    West Virginia filed a lawsuit alleging that Rite-Aid and Walgreens failed to monitor and report suspicious prescription painkiller orders and contributed to a public nuisance. The allegations are not stated as court findings.

  • 1999

    Accounting and financial-control crisis

    Rite Aid experienced severe financial and management problems in the late 1990s, including accounting concerns, debt pressure, declining investor confidence, and the resignation of senior executives. The company undertook leadership changes, store closures, refinancing, and audit-firm changes to stabilize the business.

Read more

Marketing campaigns

  • 2020Rite Aid visual identity redesign

    United States

    Rite Aid introduced a redesigned logo using blue and green, updating the visual identity of the pharmacy chain as it attempted to modernize its retail and health-services positioning.

    Outcome. The updated identity was used during the company’s final years as a national pharmacy retailer.

Brand decisions

  • 2023

    Chapter 11 restructuring and store rationalizationStrategy

    Background

    Rite Aid faced heavy debt, declining retail performance, and opioid-related lawsuits. The company announced that as many as 500 locations could close.

    Action taken

    Rite Aid filed for Chapter 11 protection, obtained financing and debt-reduction agreements, and closed hundreds of stores during the restructuring.

    Aftermath

    The company emerged in September 2024 but filed for bankruptcy again in May 2025 and moved toward liquidation.

    Bankruptcy financing and debt-reduction agreements. Approximately $3.5 billion in financing and debt reduction agreements announced (2023)

  • 2018

    Proposed Albertsons mergerM&A

    Background

    After the Walgreens transaction was reduced, Albertsons and Rite Aid proposed combining their businesses in a merger of equals.

    Action taken

    Rite Aid presented the transaction to shareholders, but the proposal failed to obtain sufficient shareholder support and was cancelled.

    Aftermath

    Rite Aid continued as a smaller standalone pharmacy retailer.

  • 2015

    Agreement to be acquired by Walgreens Boots AllianceM&A

    Background

    Walgreens proposed acquiring Rite Aid to create a larger national pharmacy chain, but regulators raised concerns about concentration in local pharmacy markets.

    Action taken

    The companies repeatedly revised the proposed transaction and considered selling hundreds of stores to address antitrust concerns. Walgreens ultimately cancelled the full merger and negotiated a smaller purchase of Rite Aid stores.

    Aftermath

    Walgreens acquired 1,932 locations in 2018, leaving Rite Aid as a substantially smaller independent chain.

    Initial announced acquisition value. Approximately $9.4 billion announced value (2015)

    • Walgreens Boots Alliance — Walgreens revised and ultimately withdrew the proposed full acquisition, then completed a smaller store purchase.
  • 2007

    Acquisition of Jean Coutu Group’s United States operationsM&A

    Background

    Rite Aid sought to expand its store base and strengthen its position in the Eastern United States through the purchase of Brooks Pharmacy and Eckerd locations.

    Action taken

    The acquisition closed after shareholder and regulatory approval, with Rite Aid divesting certain stores and subsequently converting the acquired banners to Rite Aid.

    Aftermath

    The transaction made Rite Aid the third-largest U.S. drugstore chain and brought its store count above 5,000 at its peak.

    Transaction value. Approximately $3.4 billion transaction announced (2006-2007)

  • 1995

    Abandonment of the Revco acquisitionM&A

    Background

    Rite Aid announced a proposed acquisition of Revco in a transaction valued at approximately $1.8 billion, but competition concerns and opposition from Revco executives contributed to regulatory resistance.

    Action taken

    Rite Aid abandoned the transaction after the Federal Trade Commission indicated that it intended to pursue an antitrust case.

    Aftermath

    Revco was later acquired by CVS, while Rite Aid continued pursuing regional acquisitions and internal restructuring.

Recent events

  • Rite Aid announces plan to close 63 stores[3]

    Reported:

    Rite Aid announced a plan to close 63 stores as part of a cost-reduction program. The announcement said the closures were expected to provide an annual EBITDA benefit of approximately $25 million; it did not identify the locations.

  • Natalist expands retail availability across the United States[4]

    Reported:

    Natalist announced that its products were available in nearly 6,000 stores across the United States, including expanded distribution in Target stores and rollouts at Rite Aid, Albertsons, Safeway, and Shaw's.

  • Rite Aid announces acquisition of Bartell Drugs[5]

    Reported:

    Bartell Drugs announced that it had been sold to Rite Aid for $95 million. The report describes the transaction as an acquisition but does not establish its completion.

  • Rite Aid expands COVID-19 testing sites[6]

    Reported:

    Rite Aid opened 161 additional COVID-19 self-swab testing sites, bringing its total to 258 locations across 13 U.S. states.

  • West Virginia sues Rite Aid and Walgreens over opioid distribution[2]

    Reported:

    West Virginia filed a lawsuit alleging that Rite-Aid and Walgreens failed to monitor and report suspicious prescription painkiller orders and contributed to a public nuisance. The allegations are not stated as court findings.

  • Rite Aid reveals a new logo as part of a brand refresh[7]

    Reported:

    Rite Aid revealed a new logo, replacing its classic red with a softer green, as part of a brand refresh and broader store strategy.

Sources7 sources

Cite this profile: Cite the canonical profile. /brand-wiki/rite-aid · Editorial policy · How profiles are compiled